Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 5428

1.

Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort.

Mallet J, Le Strat Y, Schürhoff F, Mazer N, Portalier C, Andrianarisoa M, Aouizerate B, Berna F, Brunel L, Capdevielle D, Chereau I, D'Amato T, Denizot H, Dubreucq J, Faget C, Gabayet F, Llorca PM, Misdrahi D, Richieri R, Rey R, Roux P, Schandrin A, Urbach M, Vidailhet P, Fond G, Dubertret C; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group, Andrianarisoa M, Aouizerate B, Bazin N, Berna F, Blanc O, Brunel L, Bulzacka E, Capdevielle D, Chereau-Boudet I, Chesnoy-Servanin G, Danion J, D'Amato T, Deloge A, Delorme C, Denizot H, Dorey JM, Dubertret C, Dubreucq J, Faget C, Fluttaz C, Fond G, Fonteneau S, Gabayet F, Giraud-Baro E, Lacelle D, Lançon C, Laouamri H, Leboyer M, Le Gloahec T, Le Strat Y, Llorca, Mallet J, Metairie E, Misdrahi D, Offerlin-Meyer I, Passerieux C, Peri P, Pires S, Portalier C, Ramet L, Rey R, Roman C, Schandrin A, Schürhoff F, Tessier A, Tronche A, Urbach M, Vaillant F, Vehier A, Vidailhet P, Vilà E, Yazbek H, Zinetti-Bertschy A.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 27;79(Pt B):332-339. doi: 10.1016/j.pnpbp.2017.06.026. [Epub ahead of print]

PMID:
28663115
2.

Clozapine as a Model for Antipsychotic Development.

Nucifora FC Jr, Mihaljevic M, Lee BJ, Sawa A.

Neurotherapeutics. 2017 Jul;14(3):750-761. doi: 10.1007/s13311-017-0552-9. Review.

PMID:
28653280
3.

Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis.

Green LK, Zareie P, Templeton N, Keyzers RA, Connor B, La Flamme AC.

Mult Scler J Exp Transl Clin. 2017 Mar 17;3(1):2055217317698724. doi: 10.1177/2055217317698724. eCollection 2017 Jan-Mar.

4.

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial.

Larsen JR, Vedtofte L, Jakobsen MSL, Jespersen HR, Jakobsen MI, Svensson CK, Koyuncu K, Schjerning O, Oturai PS, Kjaer A, Nielsen J, Holst JJ, Ekstrøm CT, Correll CU, Vilsbøll T, Fink-Jensen A.

JAMA Psychiatry. 2017 Jul 1;74(7):719-728. doi: 10.1001/jamapsychiatry.2017.1220.

PMID:
28601891
5.

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.

Tiihonen J, Mittendorfer-Rutz E, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Taipale H.

JAMA Psychiatry. 2017 Jul 1;74(7):686-693. doi: 10.1001/jamapsychiatry.2017.1322.

PMID:
28593216
6.

Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic Evidence.

Correll CU, Rubio JM, Inczedy-Farkas G, Birnbaum ML, Kane JM, Leucht S.

JAMA Psychiatry. 2017 Jul 1;74(7):675-684. doi: 10.1001/jamapsychiatry.2017.0624. Review.

PMID:
28514486
7.

Spatiotemporal Mapping Techniques Show Clozapine Impairs Neurogenic and Myogenic Patterns of Activity in the Colon of the Rabbit in a Dose-Dependent Manner.

Every-Palmer S, Lentle RG, Reynolds G, Hulls C, Chambers P, Dunn H, Ellis PM.

Front Pharmacol. 2017 Apr 24;8:209. doi: 10.3389/fphar.2017.00209. eCollection 2017.

8.

The role of atypical antipsychotics in sexuality: Road to recovery in schizophrenia.

Adam RL, Sidi H, Midin M, Zakaria H, Das S, Mat KC.

Curr Drug Targets. 2017 May 2. doi: 10.2174/1389450118666170502130126. [Epub ahead of print]

PMID:
28464773
9.

Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.

McMillan SS, Jacobs S, Wilson L, Theodoros T, Robinson G, Anderson C, Mihala G, Wheeler AJ.

BMC Psychiatry. 2017 Apr 13;17(1):139. doi: 10.1186/s12888-017-1295-1.

10.

Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients.

Solismaa A, Kampman O, Lyytikäinen LP, Seppälä N, Viikki M, Mononen N, Lehtimäki T, Leinonen E.

Eur Neuropsychopharmacol. 2017 May;27(5):442-449. doi: 10.1016/j.euroneuro.2017.03.009. Epub 2017 Apr 8.

PMID:
28400155
11.

Olanzapine-induced Pancytopenia: A Rare but Worrying Complication.

Pang N, Thrichelvam N, Naing KO.

East Asian Arch Psychiatry. 2017 Mar;27(1):35-7.

12.

Comparative study of clozapine versus risperidone in treatment-naive, first-episode schizophrenia: A pilot study.

Sahni S, Chavan BS, Sidana A, Kalra P, Kaur G.

Indian J Med Res. 2016 Nov;144(5):697-703. doi: 10.4103/ijmr.IJMR_279_15.

13.

Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.

Zheng W, Xiang YT, Yang XH, Xiang YQ, de Leon J.

J Clin Psychiatry. 2017 May;78(5):e498-e505. doi: 10.4088/JCP.16r10782.

PMID:
28355041
14.

Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia.

Kinoshita M, Numata S, Tajima A, Yamamori H, Yasuda Y, Fujimoto M, Watanabe S, Umehara H, Shimodera S, Nakazawa T, Kikuchi M, Nakaya A, Hashimoto H, Imoto I, Hashimoto R, Ohmori T.

Int J Mol Sci. 2017 Mar 14;18(3). pii: E632. doi: 10.3390/ijms18030632.

15.

Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.

Barber S, Olotu U, Corsi M, Cipriani A.

Cochrane Database Syst Rev. 2017 Mar 23;3:CD006324. doi: 10.1002/14651858.CD006324.pub3. Review.

PMID:
28333365
16.

Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.

Takeuchi H, Lee J, Fervaha G, Foussias G, Agid O, Remington G.

J Clin Psychiatry. 2017 Feb;78(2):223-228. doi: 10.4088/JCP.15m10286.

PMID:
28234436
17.

Predictors of Nonhospitalization and Functional Response in Clozapine Treatment: A Nationwide, Population-Based Cohort Study.

Köhler-Forsberg O, Horsdal HT, Legge SE, MacCabe JH, Gasse C.

J Clin Psychopharmacol. 2017 Apr;37(2):148-154. doi: 10.1097/JCP.0000000000000649.

PMID:
28225745
18.

Cardiovascular disease in patients with schizophrenia.

Kritharides L, Chow V, Lambert TJ.

Med J Aust. 2017 Feb 6;206(2):91-95.

PMID:
28152356
19.

Pharmacological treatment for antipsychotic-related constipation.

Every-Palmer S, Newton-Howes G, Clarke MJ.

Cochrane Database Syst Rev. 2017 Jan 24;1:CD011128. doi: 10.1002/14651858.CD011128.pub2. Review.

PMID:
28116777
20.

Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review.

Gillespie AL, Samanaite R, Mill J, Egerton A, MacCabe JH.

BMC Psychiatry. 2017 Jan 13;17(1):12. doi: 10.1186/s12888-016-1177-y. Review.

Supplemental Content

Loading ...
Support Center